Connect with us

Business

EU’s drug regulator backs AstraZeneca vaccine after safety investigation – Sydney Morning Herald

The regulator said the vaccine did not increase the overall risk of blood clots but cannot rule out a link with two very rare blood disorders.

Published

on

This pandemic is costing lives. We have vaccines that are safe and effective and can prevent deaths and hospitalisations. We need to use those vaccines.
The countries had been under pressure to urgently restart the AstraZeneca rollout following the EMAs conclusions.
Working with data from other agencies around the world, the EMA found the number of thromboembolic events reported during trials and the broader rollout was 469 lower than what would normally be expected in the general population.
Sabine…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending